ProBiotix Health Plc engages in the development of probiotic products for cardiovascular disease and other lifestyle conditions. It operates under the following geographical segments: UK, US, and Rest of World. The company was founded by Stephen Patrick O'Hara in 2018 and is headquartered in Wakefield, the United Kingdom.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company